Chief Accounting Officer
CG Oncology, Inc. (CGON)Equibles does not estimate personal net worth.
Get an email with a short summary when CG Oncology, Inc. publishes a filing, an earnings call transcript or a press release.
Get CGON alertsRobert Lapetina is recorded as Chief Accounting Officer at CG Oncology, Inc. (CGON) since August 5, 2025. CG Oncology, Inc. reported in an 8-K filed November 14, 2025 that Robert Lapetina resigned as interim principal financial and accounting officer, effective November 30, 2025. CG Oncology, Inc. reported in an 8-K filed July 11, 2025 that Robert Lapetina was appointed principal financial and accounting officer, effective August 5, 2025. CG Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CG Oncology, Inc. includes Arthur Kuan (CEO), Corleen M. Roche (CFO), Jim DeTore (CFO) and 4 others.
“On November 10, 2025, Robert Lapetina, interim principal financial and accounting officer of CG Oncology, Inc. (the "Company") delivered to the Company a notice of resignation from his position as interim principal financial and accounting officer of the Company. Mr. Lapetina's resignation is effective November 30, 2025.”
“On July 7, 2025, the Company appointed Robert Lapetina as principal financial and accounting officer of the Company.”
2025-08-05–present
Proxy statement
Start not stated–present
Last confirmed April 24, 2026
CGON
Biotechnology · Healthcare
Chief Accounting Officer
2025-08-05–present
